Preprint · OA
via OpenAlex
Telomere shortening & metabolic/vascular diseases.
Muthuswamy Balasubramanyam, Antonysunil Adaikalakoteswari, S. Finny Monickaraj, Viswanathan Mohan
PubMed · 2007 · ▲ 52 citations
Abstract
Telomeres are specialized DNA-protein structures located at the ends of eukaryotic chromosomes whose length is progressively reduced in most somatic cells during ageing. Over the past decade, emerging evidence has shown that the telomeres are essential regulators of cellular life span and chromosome integrity in a dynamic fashion. By inducing genomic instability, replicative senescence(definition) and apoptosis, shortening of telomeres is thought to contribute to organismal ageing. While the aetiology of cardiovascular diseases and diabetes represent a complex interaction between various risk factors overlaid on different genetic backgrounds, the conventional risk factors often did not explain the inter-individual variability related to predisposition of disease states. This underscores the need for biological indicators of ageing in evaluating the aetiology of several age-related disorders, and recent studies indicate that telomere(definition) length could qualify as an ideal marker of biological ageing. Short telomeres have been detected in senescent endothelial cells and vascular smooth muscle cells from human atherosclerotic plaque as well as in myocardial tissue from patients with end-stage heart failure and cardiac hypertrophy. In addition, telomere shortening has been demonstrated in WBCs from patients with coronary heart disease, premature myocardial infarction, hypertension and diabetes mellitus. In this review, we discuss the telomere hypothesis of ageing as well as human studies that address the role of telomeres in cardiovascular, diabetes and other cardio-metabolic pathologies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-09-29 MST
Cite this
APA
Balasubramanyam, M., Adaikalakoteswari, A., Monickaraj, S.F., & Mohan, V. (2007). Telomere shortening & metabolic/vascular diseases. <em>PubMed</em>. https://openalex.org/W2097805317
Vancouver
Balasubramanyam M, Adaikalakoteswari A, Monickaraj SF, Mohan V. Telomere shortening & metabolic/vascular diseases. PubMed. 2007.
BibTeX
@unpublished{muthuswamy2007Telome,
title = {Telomere shortening & metabolic/vascular diseases.},
author = {Muthuswamy Balasubramanyam and Antonysunil Adaikalakoteswari and S. Finny Monickaraj and Viswanathan Mohan},
journal = {PubMed},
year = {2007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Circulation Research 2006
Open access · OA
Telomere Biology and Cardiovascular Disease
Cardiovascular Research 2004
Open access · OA
Aging, telomeres, and atherosclerosis
The EMBO Journal 2019
Open access · CC-BY
Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence
Ageing Research Reviews 2009
Preprint · OA
The ageing epigenome: Damaged beyond repair?
Central Hospital, Nancy, France 2019
Open access · US-GOV
Role of Telomere Length in Arterial Smooth Muscle Cells and Circulating/Tissue Endothelial Progenitors in the Development of Atherosclerotic Lesions: Set up of the Experimental Model
Experimental and Therapeutic Medicine 2019
Open access · CC-BY